Lucarelli and colleagues in this issue of Journal of Diabetes Science and Technology describe the results of interference testing for a continuous glucose monitoring system. The authors follow the Clinical Laboratory Standards Institute guideline EP7-A2, including their conclusions, in which the concepts of a statistically significant interfering substance and a clinically important interference have been combined in a way whereby information from the experiment has been lost and could be misleading. A better way to treat the data is presented, including a simulation method to evaluate the effects of interferences. © Diabetes Technology Society.
CITATION STYLE
Krouwer, J. S. (2012). Interference testing: Why following standards is not always the right thing to do. Journal of Diabetes Science and Technology, 6(5), 1182–1184. https://doi.org/10.1177/193229681200600523
Mendeley helps you to discover research relevant for your work.